The Pounce XL Thrombectomy System received U.S. Food and Drug Administration (FDA) 510(k) clearance in September 2024, and is currently in limited market release (LMR), with full commercial launch ...

Surmodics (SRDX) announced the successful early clinical use of its Pounce XL Thrombectomy System. The Pounce XL Thrombectomy System received FDA 510(k) clearance in September 2024, and is ...

Surmodics, Inc. SRDX received the FDA’s 510(k) clearance for its Pounce XL Thrombectomy System yesterday. Following the ...

Akura Medical has enrolled the first subject in the multi-centre QUADRA-PE trial, which is assessing its flagship Katana thrombectomy system in treating acute pulmonary embolism (PE) patients.

With full enrollment completed, the company is one step closer to demonstrating the potential of the Aventus Thrombectomy System to revolutionize PE treatment. “This trial is a key step toward ...